FRESEN.MED.CARE KGAA O.N.
FRESEN.MED.CARE KGAA O.N./ DE0005785802 /
FME
|
3/22/2023 6:08:22 PM
|
Chg.
+0.480
|
Volume |
Bid6:08:22 PM |
Ask6:08:22 PM |
Market Capitalization |
Dividend Y. |
P/E Ratio |
|
37.590EUR
|
+1.29%
|
-
Turnover: - |
37.590Bid Size: - |
37.780Ask Size: - |
11.06 bill.EUR |
3.58% |
11.40 |
Business description
Fresenius Medical Care is the world’s leading provider of products and services for people with chronic kidney failure. Around 2.8 M patients with this disease worldwide regularly undergo dialysis treatment. Dialysis is a vital blood cleansing procedure that substitutes the function of the kidney in case of kidney failure.
Management board & Supervisory board
| CEO |
| Carla Kriwet (ab 1.01.2023) |
| Management board |
| Helen Giza, Dr. Katarzyna Mazur-Hofsäß, Frank Maddux, MD, William Valle |
| Supervisory board |
| Dr. Dieter Schenk, Dr. Dorothea Wenzel, Gregory Sorensen, MD, Pascale Witz, Prof. Dr. Gregor Zünd, Rolf A. Classon |
Company data
| Name: |
Fresenius Medical Care AG & Co. KGaA |
| Address: |
Else-Kröner-Straße 1,D-61352 Bad Homburg |
| Phone: |
+49-6172-609-0 |
| Fax: |
+49-6172-609-2301 |
| E-mail: |
-
|
| Internet: |
www.fmc-ag.de |
| Industry: |
Healthcare |
| Sector: |
Medical Products |
| Sub sector: |
Advanced Medical Devices |
| End of financial year: |
12/31 |
| Free Float: |
44.95% |
| IPO date: |
10/2/1996 |
Investor relations
| Name: |
Dr. Dominic Heger |
| IR phone: |
+49-6172-609-2601 |
| IR Fax: |
- |
| IR e-mail: |
ir@fmc-ag.com
|
Main Shareholders
| Freefloat |
|
44.95% |
| Fresenius SE & Co. KGaA |
|
32.00% |
| Thornburg Investment Management Inc. |
|
4.96% |
| BlackRock, Inc. |
|
3.16% |
| Richard Pzena |
|
3.01% |
| Artisan Partners Asset Management Inc. |
|
2.99% |
| Harris Associates L.P. |
|
2.98% |
| FIL Limited |
|
2.98% |
| Norges Bank |
|
2.97% |